1. Home
  2. BPMC vs LLYVK Comparison

BPMC vs LLYVK Comparison

Compare BPMC & LLYVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • LLYVK
  • Stock Information
  • Founded
  • BPMC 2008
  • LLYVK 1991
  • Country
  • BPMC United States
  • LLYVK United States
  • Employees
  • BPMC N/A
  • LLYVK 1100
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • LLYVK Broadcasting
  • Sector
  • BPMC Health Care
  • LLYVK Industrials
  • Exchange
  • BPMC Nasdaq
  • LLYVK Nasdaq
  • Market Cap
  • BPMC 5.8B
  • LLYVK 6.9B
  • IPO Year
  • BPMC 2015
  • LLYVK N/A
  • Fundamental
  • Price
  • BPMC $101.35
  • LLYVK $72.95
  • Analyst Decision
  • BPMC Buy
  • LLYVK
  • Analyst Count
  • BPMC 18
  • LLYVK 0
  • Target Price
  • BPMC $125.88
  • LLYVK N/A
  • AVG Volume (30 Days)
  • BPMC 789.4K
  • LLYVK 341.3K
  • Earning Date
  • BPMC 05-01-2025
  • LLYVK 01-01-0001
  • Dividend Yield
  • BPMC N/A
  • LLYVK N/A
  • EPS Growth
  • BPMC N/A
  • LLYVK N/A
  • EPS
  • BPMC N/A
  • LLYVK 0.27
  • Revenue
  • BPMC $562,121,000.00
  • LLYVK N/A
  • Revenue This Year
  • BPMC $44.49
  • LLYVK $7.29
  • Revenue Next Year
  • BPMC $33.04
  • LLYVK N/A
  • P/E Ratio
  • BPMC N/A
  • LLYVK $267.97
  • Revenue Growth
  • BPMC 99.19
  • LLYVK N/A
  • 52 Week Low
  • BPMC $73.04
  • LLYVK $33.50
  • 52 Week High
  • BPMC $121.90
  • LLYVK $81.66
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 56.34
  • LLYVK 45.13
  • Support Level
  • BPMC $94.38
  • LLYVK $71.48
  • Resistance Level
  • BPMC $102.52
  • LLYVK $78.02
  • Average True Range (ATR)
  • BPMC 3.77
  • LLYVK 2.02
  • MACD
  • BPMC -0.38
  • LLYVK -0.74
  • Stochastic Oscillator
  • BPMC 79.29
  • LLYVK 19.19

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About LLYVK Liberty Media Corporation

Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.

Share on Social Networks: